课题基金 / 基金详情

Ovarian anti-Mullerian hormone: what does it do in the normal ovary and why is it so high in polycystic ovary syndrome?

Ovarian anti-Mullerian hormone: what does it do in the normal ovary and why is it so high in polycystic ovary syndrome?
卵巢抗苗勒氏管激素:它在正常卵巢中起什么作用?为什么它在多囊卵巢综合征中如此高?
批准号:
G0700916/1
负责人:
Helen Mason
金额:
$39.51万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Helen Mason的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the womb, boy babies develop part of their reproductive system because of the actions of a hormone called anti-Mullerian hormone (AMH). Interestingly, this hormone has now been shown to play a part in adult women in that it is involved in the working of the ovary. In the ovary each month an egg is grown and released. We have found that only those eggs which have got rid of AMH manage to grow. This is important because we have also found that the levels of this hormone are very high in a common condition which causes infertility. We now need to find out why the levels are high in these women and what exactly AMH does in the ovary. We hope that this will allow us to help these women to have better fertility in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SunSpaceArt - Building on Success
  • 批准号:
    ST/X006166/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $6.37万
  • 财政年份:
    2023
  • 负责人:
    Helen Mason
  • 依托单位:
SunSpaceArt - 2021
  • 批准号:
    ST/W001896/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $2.61万
  • 财政年份:
    2021
  • 负责人:
    Helen Mason
  • 依托单位:
SunSpaceArt - Phase II
  • 批准号:
    ST/S001042/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $9.68万
  • 财政年份:
    2018
  • 负责人:
    Helen Mason
  • 依托单位:
UNDERSTANDING THE DYNAMICAL SOLAR ATMOSPHERE
  • 批准号:
    ST/P000665/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $31.67万
  • 财政年份:
    2017
  • 负责人:
    Helen Mason
  • 依托单位:
国内基金
海外基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    程瑶
  • 依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
  • 批准号:
    JCZRQN202500319
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    仇凤启
  • 依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究